Official EU label nameGlossary entry 10746

GALLIUM MALTOLATE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:108560-70-9

Ingredient index records:

GALLIUM MALTOLATE

Cosmetic functions: SKIN CONDITIONING

Gallium, tris[3-(hydroxy-\KO)-2-methyl-4H-pyran-4-onato-\KO4]- (OC-6-21)

Open full local profile

1 matched or reported name

GALLIUM MALTOLATE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name GALLIUM MALTOLATE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 108560-70-9

CAS 108560-70-9PubChem CID 9846339

Gallium Maltolate

Gallium maltolate is Titan’s novel oral agent in development for the potential treatment of chronic bacterial infections, bone disease and cancer. — DrugBank

IUPAC name: gallium tris(2-methyl-4-oxopyran-3-olate)

Molecular formula: C18H15GaO9
Molecular weight: 445.0 g/mol
Exact mass: 443.99718 Da
Topological polar surface area: 148.0 Å²
Hydrogen-bond donors: 0
Hydrogen-bond acceptors: 9
Covalent units: 4
Defined stereocentres: 0

Also known as

17LEI49C2Gtris(maltolato)gallium(III)RefChem:142192tris(3-hydroxy-2-methyl-4H-pyran-4-onato)gallium(III)4H-pyran-4-one, 3-hydroxy-2-methyl-, gallium salt (3:1)gallium tris(2-methyl-4-oxo-4H-pyran-3-olate)gallium;2-methyl-4-oxopyran-3-olateC18H15GaO9

6 more reported names

Gallium maltolate [WHO-DD]ASYYOZSDALANRF-UHFFFAOYSA-KDA-53477gallium;2-methyl-4-oxidanylidene-pyran-3-olate3-bis[(2-methyl-4-oxopyran-3-yl)oxy]gallanyloxy-2-methylpyran-4-oneGALLIUM, TRIS(3-(HYDROXY-.KAPPA.O)-2-METHYL-4H-PYRAN-4-ONATO-.KAPPA.O4)-, (OC-6-21)-

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

PubMed:17916007
PubMed:17600139
PubMed:16827101

Evidence from additional scientific databases

NIH PubChem PUG-View

Exact identifier match9846339

Attributed physical-property, hazard, environmental and use annotations.

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status

Source	Result	Checked
NIH PubChem PUG-View	Exact match	2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision